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Alzheimer's Disease (AD) is characterized by inflammation and 
neurodegeneration in the brain due to the presence of extracellular amyloid 
beta (A β) plaques and neurofibrillary tangles. Microglial and astrocyte 
cells associated with these plaques and tangles have been shown to release 
cytokines in AD patients, which have a proinflammatory effect on the brain. 
The P2Y2 receptor (P2Y2R) is a receptor protein that is up-regulated in 
response to damage or stress in a variety of tissues, including blood vessels 
and salivary gland epithelium. Recently our laboratory has shown that 
activation of the P2Y2R enhances α -secretase-dependent amyloid precursor 
protein (APP) processing. APP is proteolytically processed by β - and γ -
secretases to release neurodegenerative A β. Alternatively, APP can be 
cleaved within the A β domain by α -secretase releasing the non-amyloidogenic 
product, sAPP α, which has been shown to have neuroprotective properties. 
Primary neurons have low P2Y2R expression, however, it has been demonstrated 
that cytokines up-regulate P2Y2R in smooth muscle cells. Therefore, this 
study will explore if cytokines up-regulate P2Y2R expression in primary rat 
neurons and in SH-SY5Y human neuroblastoma cells. Primary rat neurons and SH-
SY5Y human neuroblastoma cells were plated on glass cover slips 24 or 48 
hours with individual treatment, or a combination of, human interleukin-1 β 
(IL1- β), tumor necrosis factor α (TNF α), and interferon γ (IF γ). P2Y2R 
activity was measured by increases in intracellular calcium concentration 
([Ca2+]i ) in response to the P2Y2R agonist UTP. Results support the 
hypothesis that P2Y2R is up-regulated by cytokines in neuronal cells. 
Furthermore, real-time PCR results indicate a two-fold increase in P2Y2R mRNA 
after cytokine treatment. Therefore, activation of the up-regulated P2Y2R in 
stressed neurons generates a neuroprotective (sAPP α) rather than 
neurodegenerative (A β) peptide. These results could have a substantial 
impact on the understanding and treatment of neurological disorders such as 
AD. 
